BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 32370696)

  • 1. Risk Factors for Posttransplant Erythrocytosis: Parathyroid Hormone Paradox?
    Yeter HH; Fettahoglu F; Yesiloglu E; Akcay O; Korucu B; Bali M; Derici U
    Exp Clin Transplant; 2024 Feb; 22(2):103-107. PubMed ID: 32370696
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Posttransplant metabolic complications in living-related renal allograft recipients of Kashmir Valley.
    Shera IA; Yousuf Q; Mir MA; Wani IA; Najar MS
    Exp Clin Transplant; 2014 Feb; 12(1):25-30. PubMed ID: 24471720
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Posttransplant erythrocytosis in renal transplant recipients at Jeddah Kidney Center, Kingdom of Saudi Arabia.
    Basri N; Gendo MZ; Haider R; Abdullah KA; Hassan A; Shaheen FA
    Exp Clin Transplant; 2007 Jun; 5(1):607-9. PubMed ID: 17617052
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Post transplant erythrocytosis in hypercalcemic renal transplant recipients.
    Kurella M; Butterly DW; Smith SR
    Am J Transplant; 2003 Jul; 3(7):873-7. PubMed ID: 12814479
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence and risk factors for tertiary hyperparathyroidism in kidney transplant recipients.
    Sutton W; Chen X; Patel P; Karzai S; Prescott JD; Segev DL; McAdams-DeMarco M; Mathur A
    Surgery; 2022 Jan; 171(1):69-76. PubMed ID: 34266650
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Postrenal transplant erythrocytosis: a review of 53 patients.
    Wickre CG; Norman DJ; Bennison A; Barry JM; Bennett WM
    Kidney Int; 1983 May; 23(5):731-7. PubMed ID: 6348369
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictive factors for persistent hypercalcemia following parathyroidectomy in patients with persistent hyperparathyroidism after kidney transplantation: a retrospective cohort study.
    Kim BC; Kim H; Baek CH; Kim YH; Pak SJ; Kwon D; Cho JW; Lee YM; Sung TY; Chung KW; Kim WW
    Int J Surg; 2024 Feb; 110(2):902-908. PubMed ID: 37983758
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Posttransplant Erythrocytosis Among Egyptian Living-Donor Kidney Transplant Recipients.
    Abouelenein RK; Refaie AF; Alhendy YA; Al Okily AM; Elserwy NA; Mashaly ME; Abbas MH; Bakr MA
    Exp Clin Transplant; 2018 Nov; ():. PubMed ID: 30501588
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypercalcemia secondary to persistent hyperparathyroidism in kidney transplant patients: analysis after a year with cinacalcet.
    Guerra R; Auyanet I; Fernández EJ; Pérez MÁ; Bosch E; Ramírez A; Suria S; Checa MD
    J Nephrol; 2011; 24(1):78-82. PubMed ID: 20437396
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinicopathological analysis of persistent hypercalcemia and hyperparathyroidism after kidney transplantation in long-term dialysis patients.
    Nakamura M; Tanaka K; Marui Y; Tomikawa S
    Ther Apher Dial; 2013 Oct; 17(5):551-6. PubMed ID: 24107283
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Erythrocytosis after renal transplantation: review of 101 cases.
    Einollahi B; Lessan-Pezeshki M; Nafar M; Pour-Reza-Gholi F; Firouzan A; Farhangi F; Pourfarziani V
    Transplant Proc; 2005 Sep; 37(7):3101-2. PubMed ID: 16213319
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tertiary hyperparathyroidism after renal transplantation: operative indications.
    D'Alessandro AM; Melzer JS; Pirsch JD; Sollinger HW; Kalayoglu M; Vernon WB; Belzer FO; Starling JR
    Surgery; 1989 Dec; 106(6):1049-55; discussion 1055-6. PubMed ID: 2588112
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of contributing factors of post transplant erythrocytosis in renal transplant patients.
    Ahmed S; Ahmed E; Naqvi R; Qureshi S
    J Pak Med Assoc; 2012 Dec; 62(12):1326-9. PubMed ID: 23866484
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low-Grade Persistent Hyperparathyroidism After Pediatric Renal Transplant.
    Gulleroglu K; Baskin E; Moray G; Haberal M
    Exp Clin Transplant; 2016 Jun; 14(3):294-8. PubMed ID: 26581346
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationship of posttransplantation erythrocytosis to hypercalcemia in renal transplant recipients.
    Akcay A; Kanbay M; Huddam B; Usluogullari CA; Arat Z; Ozdemir FN; Haberal M
    Transplant Proc; 2005 Sep; 37(7):3103-5. PubMed ID: 16213320
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Posttransplant erythrocytosis: case report and review of newer treatment modalities.
    Perazella MA; Bia MJ
    J Am Soc Nephrol; 1993 Apr; 3(10):1653-9. PubMed ID: 8318681
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changes in blood pressure and renal function following subtotal parathyroidectomy in renal transplant patients presenting with persistent hypercalcemic hyperparathyroidism.
    Rostaing L; Moreau-Gaudry X; Baron E; Cisterne JM; Monroziès-Bernadet P; Durand D
    Clin Nephrol; 1997 Apr; 47(4):248-55. PubMed ID: 9128792
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Elevated parathyroid hormone one year after kidney transplantation is an independent risk factor for graft loss even without hypercalcemia.
    Okada M; Tominaga Y; Sato T; Tomosugi T; Futamura K; Hiramitsu T; Ichimori T; Goto N; Narumi S; Kobayashi T; Uchida K; Watarai Y
    BMC Nephrol; 2022 Jun; 23(1):212. PubMed ID: 35710357
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Parathyroid hormone: a determinant of posttransplant blood pressure regulation.
    McCarron DA; Muther RS; Plant SB; Krutzik S
    Am J Kidney Dis; 1981 Jul; 1(1):38-44. PubMed ID: 7036714
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Causes of hypercalcemia in renal transplant recipients: persistent hyperparathyroidism and others.
    Moyses-Neto M; Garcia TMP; Nardin MEP; Muglia VA; Molina CAF; Romao EA
    Braz J Med Biol Res; 2021; 54(6):e10558. PubMed ID: 33909856
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.